about
The Role of Protein-Protein and Protein-Membrane Interactions on P450 FunctionBiomembrane models and drug-biomembrane interaction studies: Involvement in drug design and developmentInherent and acquired resistance to paclitaxel in hepatocellular carcinoma: molecular events involvedInteraction of aspirin (acetylsalicylic acid) with lipid membranesPrediction of the permeability of neutral drugs inferred from their solvation propertiesOptically-controlled platforms for transfection and single- and sub-cellular surgery.A one-dimensional continuum elastic model for membrane-embedded gramicidin dimer dissociation.A method to predict blood-brain barrier permeability of drug-like compounds using molecular dynamics simulationsCellular membrane phospholipids act as a depository for quaternary amine containing drugs thus competing with the acetylcholine/nicotinic receptor.Amphiphile regulation of ion channel function by changes in the bilayer spring constant.Drug resistance in breast cancer cells: biophysical characterization of and doxorubicin interactions with membrane lipids.Biomimetic interfaces based on S-layer proteins, lipid membranes and functional biomoleculesThe application of solid-state NMR spectroscopy to study candesartan cilexetil (TCV-116) membrane interactions. Comparative study with the AT1R antagonist drug olmesartanThiazolidinedione insulin sensitizers alter lipid bilayer properties and voltage-dependent sodium channel function: implications for drug discoveryPhosphoinositides alter lipid bilayer properties.Downregulation of caveolin-1 increases the sensitivity of drug-resistant colorectal cancer HCT116 cells to 5-fluorouracil.Measuring selective estrogen receptor modulator (SERM)-membrane interactions with second harmonic generationEmulsomes meet S-layer proteins: an emerging targeted drug delivery system.Amphiphilic drug interactions with model cellular membranes are influenced by lipid chain-melting temperatureJanus Copper Mesh Film with Unidirectional Water Transportation Ability toward High Efficiency Oil/Water Separation.Dendritic Guanidines as Efficient Analogues of Cell Penetrating PeptidesEffects of Cations on the Behaviour of Lipid Cubic PhasesIntroducing Stable Radicals into Molecular Machines.Membrane fatty acid heterogeneity of leukocyte classes is altered during in vitro cultivation but can be restored with ad-hoc lipid supplementation.Solvation free energies and partition coefficients with the coarse-grained and hybrid all-atom/coarse-grained MARTINI models.Losartan's affinity to fluid bilayers modulates lipid-cholesterol interactions.Host perturbation in a β-hydroquinone clathrate studied by combined X-ray/neutron charge-density analysis: implications for molecular inclusion in supramolecular entities.Experimental and theoretical studies of emodin interacting with a lipid bilayer of DMPC.Determination of nanostructure of liposomes containing two model drugs by X-ray scattering from a synchrotron source.NMR study of the interaction of fluorescent 3-hydroxy-4-pyridinone chelators with DMPC liposomes.Inspired and stabilized by nature: ribosomal synthesis of the human voltage gated ion channel (VDAC) into 2D-protein-tethered lipid interfaces.Entropy and Polarity Control the Partition and Transportation of Drug-like Molecules in Biological Membrane.Evaluation of the effect of fluorination on the property of monofluorinated dimyristoylphosphatidylcholines.Dependence of norfloxacin diffusion across bilayers on lipid composition.Interaction between ganglioside G(M1) and diosgenin in langmuir monolayers at the air/water interface.Droplet and Fluid Gating by Biomimetic Janus Membranes
P2860
Q27345454-E339D21C-B6E6-4574-8BEE-2B03D740024DQ28477404-541B3F7C-A0F4-4739-BF80-CCCAD2DA67D5Q28486233-D080AE89-F988-4491-8997-72D9A7D0FE0DQ28730544-8CC115AA-99CE-476B-A973-9544FD2648F6Q29048210-D23039E6-4E96-455E-B49B-F8120B0C22D4Q30357095-EB2C2433-D123-4EE5-81C5-AED21636F9C2Q33822097-14EB4568-3D85-478A-A5B9-6D04DB6BF16DQ34031018-360F21E0-A5F5-4110-BAFC-D2A479364C37Q34086865-207EA1CE-7562-4F83-9EBA-8CE866664364Q34100444-52ECAB71-E77A-44DD-8104-799271A499B5Q34384873-5D5FD857-9E2D-4D6B-83E5-29267C2458B5Q34419414-F5407894-1AA1-482B-A025-71EE72B816C1Q35063904-2C3FBB5D-5421-4CCB-BFF9-F13BF0E90CF7Q35146426-7C12514D-F3C5-45D3-B0B4-DDF7A540DB02Q36878011-179749C2-822B-406A-BBFB-B3D0DA806F38Q37593963-81F2CEBF-EB4B-4CD2-9AAC-B349C62156AEQ37731586-E859CE32-F71D-4414-9A91-E70A54CE6395Q38361935-23663AF7-050D-4FA6-9C34-72E9D2BE792DQ38594358-99D0FABA-FAB0-4C63-A3D6-CECDDFF52385Q38794370-A9B39956-9726-4357-83DA-AD71D5E9E431Q38974213-99BE5083-265D-4BD6-99F5-3602BEE71640Q41419663-355E3AA9-9BF0-4C52-9B00-CFE7EEDC1FE2Q41849391-88BDB621-D3DE-4480-A0B8-F4AD2C023464Q41904365-3D397FBC-1E56-490B-B053-7629CC67E29AQ43730054-E1FBEF05-90D7-494C-A3E6-49B145762797Q44196432-849299BA-9C7D-4719-BB0D-9FD90B917A88Q44564524-789131FD-320E-477C-8948-FF9383E6E38BQ45383532-16C2F6A1-9359-4562-BAAC-F0969F2F9C22Q45892872-13F25821-7970-41A6-BCE0-D9CD94FA78DEQ46604705-FB0C074A-7700-41C3-A85E-35F7849CD589Q46691076-6134ACA0-DEFF-4CB5-8836-CD8D54489E4CQ47119154-42E4E570-333C-4769-8AE2-A2127E01C4B2Q51076711-D0EB55A0-9E68-47D0-9647-7179E90F8C6DQ51471810-FB1BFD14-CF51-4F94-AFB4-6E46451035F7Q54518879-89DDA212-1653-413B-8237-5E91304AD184Q57695334-C696327D-070B-4495-BF30-9854FCDB9053
P2860
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 23 June 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Drug interactions with lipid membranes.
@en
Drug interactions with lipid membranes.
@nl
type
label
Drug interactions with lipid membranes.
@en
Drug interactions with lipid membranes.
@nl
prefLabel
Drug interactions with lipid membranes.
@en
Drug interactions with lipid membranes.
@nl
P2093
P356
P1476
Drug interactions with lipid membranes.
@en
P2093
Annela M Seddon
Antony Gee
Duncan Casey
Richard H Templer
Robert V Law
P304
P356
10.1039/B813853M
P577
2009-06-23T00:00:00Z